Literature DB >> 2837305

The use of varicella vaccine in Britain.

H O Kangro, R B Heath.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2837305      PMCID: PMC2545657          DOI: 10.1136/bmj.296.6630.1194-c

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  7 in total

1.  The risk of zoster after varicella vaccination in children with leukemia.

Authors:  R Lawrence; A A Gershon; R Holzman; S P Steinberg
Journal:  N Engl J Med       Date:  1988-03-03       Impact factor: 91.245

Review 2.  Varicella: complications and costs.

Authors:  S R Preblud
Journal:  Pediatrics       Date:  1986-10       Impact factor: 7.124

3.  Hell's fire and varicella-vaccine safety.

Authors:  S A Plotkin
Journal:  N Engl J Med       Date:  1988-03-03       Impact factor: 91.245

Review 4.  Worldwide experience with the Oka-strain live varicella vaccine.

Authors:  F E Andre
Journal:  Postgrad Med J       Date:  1985       Impact factor: 2.401

5.  Efficacy of varicella vaccine in patients with solid tumours.

Authors:  R B Heath; J S Malpas; H O Kangro; A Ward; J M McEniery; J E Kingston
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

6.  Attenuation and laboratory markers of the Oka-strain varicella-zoster virus.

Authors:  M Takahashi; Y Hayakawa; K Shiraki; K Yamanishi; Y Asano; T Ozaki
Journal:  Postgrad Med J       Date:  1985       Impact factor: 2.401

7.  A benefit-cost analysis of a childhood varicella vaccination programme.

Authors:  S R Preblud; W A Orenstein; J P Koplan; K J Bart; A R Hinman
Journal:  Postgrad Med J       Date:  1985       Impact factor: 2.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.